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HerpesvirusMarek' disease virus serotype-1, also know as Gallid herpesvirus 2 (GaHV-2), elicits T-cell lymphomas in
chickens. The GaHV-2 genome encodes an oncoprotein, Meq, with similarity to the Jun/Fos family of
proteins. We have previously shown that Meq homodimers are not sufﬁcient to induce lymphomas in
chickens. In this study, we investigated the role of Meq heterodimers in the pathogenicity of GaHV-2 by
generating a chimeric meq gene, which contains the leucine zipper region of Fos (meqFos). A recombinant
virus containing the meqFos gene in place of parental meq, rMd5-MeqFos, was not capable of transforming
chicken lymphocytes, indicating that heterodimerization of Meq alone is not sufﬁcient for transformation. In
addition, the recovery of the oncogenic phenotype by a recombinant virus encoding one copy each of
MeqGCN (homodimer) and MeqFos (heterodimer) conclusively demonstrates that both homo and
heterodimerization of Meq are required for oncogenesis.athobiology, College of Veteri-
VMR, Bldg. 1197, Texas A&M
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Marek's disease (MD) is a lymphoproliferative disease of chickens
caused by Gallid herpesvirus-2 (GaHV-2) which, together with closely
related Gallid herpesvirus-3 (GaHV-3) and Meleagrid herpesvirus-1
(MeHV-1) is classiﬁed in the genus Mardivirus within the subfamily
Alphaherpesvirinae (ICTVdB-Management, 2006).
The highly oncogenic nature of GaHV-2 suggested the presence of
a viral oncogene(s). Genome sequence analysis conﬁrmed the
presence of a putative oncogene, meq, unique to GaHV-2. The meq
gene is named after the EcoQ fragment where it is located, “Marek'sEcoQ”, and two copies are found in the viral genome within the
terminal repeat long (TRL) and internal repeat long (IRL) regions
(Peng et al., 1992; Ross et al., 1997; Ross, 1999; Silva et al., 2001;
Tulman et al., 2000). Meq is a 339 amino acid nuclear phosphoprotein
that is abundantly expressed in transformed cells. The structure of
Meq is well deﬁned. Meq contains nuclear and nucleolar localization
signals, a bZIP (basic-region leucine zipper) domain and a proline rich
transactivation/repression domain (Kung et al., 2001; Liu et al., 1997;
Qian et al., 1996). The bZIP domain of Meq shares signiﬁcant
homology, with the protooncogene c-Jun, a transcription factor of
the AP-1 (activating protein) complex (Jones et al., 1992). AP-1
transcription factors are well-described proteins that include the Jun,
Fos and ATF/CREB families. AP-1 proteins are characterized by their
ability to bind and regulate sequence speciﬁc gene elements, AP-1
sites, which are found inmany genes associatedwith cell proliferation
(Shaulian and Karin, 2001). Transformation by deregulated expres-
sion of c-Jun, c-Fos and their viral counterparts v-Jun and v-Fos is well
documented. The shared homology between Meq and c-Jun suggests
Meq may transform through similar mechanisms (Milde-Langosch,
2005; Vogt, 2001; Vogt and Bader, 2005).
Fig. 1. Cosmid clones used to recover recombinant viruses. (A) Organization of the
serotype 1 MDV genome. (B) Schematic representation of the overlapping cosmid
clones used to reconstitute recombinant viruses, rMd5 and rMeqFos, derived from a
very virulent (vv) strain of MDV (Md5). (C) Location of EcoQ fragment andMeq gene in
cosmids SN5 and A6. (D) Location of KpnI site described in Materials and methods,
located within the EcoQ fragment at nucleotide 385 of the meq gene. (E) Schematic
representation of the Meq protein and Meq and Fos leucine zippers (LZ). The DNA
binding basic regions (BR1 and BR2) and transactivation domains, are depicted. The LZ
sequence of parental Meq and c-Fos used to replace parental Meq LZ in rMd5-MeqFos
are shown. Asterisks indicate the conserved leucine sites.
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nature of Meq, which has been shown to promote transformation,
anchorage-independent growth, cell-cycle progression, and anti-
apoptotic activity (Ajithdoss et al., 2009; Liu et al., 1998, 1999).
More recently, in vitro expression of Meq was shown to upregulate
genes similar to those upregulated by v-Jun, suggesting that Meq
transforms via a v-Jun transforming pathway (Levy et al., 2005). The
conclusive role of Meq in transformation was conﬁrmed by the
generation of a Meq-negative recombinant virus, which failed to
cause tumors in infected chickens. (Lupiani et al., 2004). The essential
role of Meq in GaHV-2 transformation has been further supported by
generation of Meq mutant viruses, such as Meq C-terminal binding
mutant (pRB-1B-Ct20) and more recently Meq homodimer mutant
virus (rMd5-MeqGCN) both of which are non-oncogenic (Brown et al.,
2006; Suchodolski et al., 2009).
It has been shown that the leucine zipper region of bZIP proteins
determines the dimerization partners of bZIP proteins, which in turn
are important determinants of DNA binding speciﬁcity and therefore
transcriptional regulation. For example, different c-Jun dimers have
been shown to play distinct roles in transformation, i.e. anchorage or
serum independent growth (Vogt, 2001). Like c-Jun, Meq can both
homodimerize and heterodimerize and has the ability to dimerize
with c-Jun, Fos, CREB and ATF members. The DNA binding properties
ofMeq depend on its dimerization partner (Levy et al., 2003). Previous
characterization of the in vitro DNA binding properties of Meq
revealed Meq/c-Jun heterodimers bind AP-1 sequences with greater
afﬁnity than Meq homodimers (Levy et al., 2003; Qian et al., 1996). In
addition, Meq and c-Jun were shown to bind AP-1 sequences, but only
Meq was shown to bind sequences contained in the GaHV-2 origin of
replication (Ori). Transcriptional analysis of Meq on the AP-1-like
containing meq promoter, and the lytic pp14/38 bidirectional
promoter which contains the GaHV-2 Ori, revealed that Meq
transactivates the meq promoter but represses the bidirectional
pp14/38 promoter (Levy et al., 2003). Meq also has been shown to
bind the immediate early ICP4 promoter region by chromatin
immunoprecipitation analysis therefore potentially regulating other
lytic genes (Levy et al., 2003). This, together with luciferase reporter
data, suggests that Meq heterodimers activate AP-1 containing
promoters, therefore potentially activating genes associated with cell
proliferation, while Meq homodimers may repress genes associated
with lytic infection and consequently may be involved in regulating
lytic or latent infection. Collectively, these data point to a role of Meq
heterodimers in transformation andMeq homodimers in regulation of
viral replication.
In order to delineate the functions of Meq and address the role of
Meq homodimers in GaHV-2 pathogenesis, we recently reported a
recombinant Meq mutant virus (rMd5-MeqGCN) expressing a
chimeric meq gene (MeqGCN), which allowed for only Meq homo-
dimer formation. Although this virus replicated in vitro and in vivo,
the ability to transform lymphocytes was lost, supporting a role for
Meq heterodimers in transformation (Suchodolski et al., 2009).
In order to evaluate the role of Meq/c-Jun heterodimers in GaHV-2
pathogenesis, we constructed a recombinant virus that predominant-
ly allowed for the formation of Meq/c-Jun heterodimers by substi-
tuting the parentalMeq leucine zipper with the leucine zipper of c-Fos
(MeqFos). The replication of rMd5-MeqFos during early cytolytic
infection in lymphoid organs was not affected, however, infected
chickens did not develop gross tumors. These results are in agreement
with those recently reported for another Meq mutant virus that does
not homodimerize but heterodimerizes with c-Jun resulting in
complete loss of oncogenicity, suggesting that heterodimers alone
are not sufﬁcient for transformation of lymphocytes (Brown et al.,
2009). In addition, our studies with a double mutant virus, rMd5-
MeqFos/GCN, which contains one copy ofmeqGCN gene (homodimer)
and one copy of meqFos (heterodimer) provide the ﬁrst in vivo
evidence that both homo and heterodimers are involved in com-plementing pathways in GaHV-2 pathogenesis as thismutant thatwas
able to transform lymphocytes.
Results
Mutations in the leucine zipper of Meq are sufﬁcient to confer
heterodimerization with c-Jun
It iswell documented that the speciﬁc aminoacid residueswithin the
leucine zipper of bZIP proteins determine their dimerization properties.
Among these transcription factors, c-Fos has been extensively studied
and it is known that its leucine zipper exclusively forms heterodimers
with the Jun family of transcription factors (Hai and Curran, 1991;
Kouzarides and Ziff, 1989; Ransone et al., 1990). Similar to other
studies (Castellazzi et al., 1993; Hai and Curran, 1991; Hartl and Vogt,
1992; Jurdic et al., 1995; Ransone et al., 1990) we utilized the leucine
zipper region of c-Fos in place of the parental leucine zipper of Meq to
study the function of Meq/Jun heterodimers in GaHV-2 pathogenesis.
The leucine zipper ofmeqwas successfully “swapped”with the leucine
zipper of c-fos using overlapping PCR, resulting in a Meq heterodimer
mutant, MeqFos (Fig. 1).
Co-immunoprecipitation experiments were performed to test the
dimerization of MeqFos by transfecting 293 T cells with pcDNA
vectors expressing Flag and HA tagged Meq, MeqFos, and c-Jun
constructs. Cell lysates were immunoprecipitated with anti-FLAG
antibody followed byWestern blot analysis to evaluate if the presence
of HA-tagged proteins were in the dimer complex. As demonstrated in
Fig. 2.Heterodimerization of Meq andMeqFos. (A) Co-immunoprecipitation analysis of tagged Meq and MeqFos proteins. 293 T cells were transfected with the indicated expression
plasmids. Five percent of the total cell lysates that were used for co-immunoprecipitation were also included as controls. MeqFos heterodimerizes with wild type (wt) Meq (left
panel) but does not homodimerize (right panel and arrow). (B) MeqFos retains ability to form heterodimers with c-Jun. The indicated expression plasmids were cotransfected in
293 T cells. Five percent of the total cell lysates that were used for immunoprecipitation were also included in the same gel as a control. Both Meq and MeqFos effectively precipitate
with c-Jun.
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however, only a small amount of HA-MeqFos co-precipitated with
Flag-MeqFos, therefore demonstrating MeqFos preferentially forms
heterodimers. Co-immunoprecipitation was also performed to con-
ﬁrm the ability of MeqFos to dimerize with c-Jun. Cells were
transfected with Flag-Meq and Jun-HA as a positive control, and
Flag-MeqFos and Jun-HA. As shown in Fig. 2B both Flag-Meq and Flag-
MeqFos effectively co-precipitate with Jun-HA, therefore verifying
dimerization of MeqFos with c-Jun.
Meq heterodimer mutant (MeqFos) retains DNA binding, transactivation
and repressive functions
Previouswork has shown that Meq homodimers and heterodimers
have different DNAbinding afﬁnities. Although bothMeq homodimers
and heterodimers bound AP-1 sequences, Meq together with c-Jun
bound AP-1 sequences with greater afﬁnity than Meq alone. In
addition, Meq alone bound the GaHV-2 Ori located in the pp38/14
bidirectional promoter by EMSA analysis using bacterial expressed
proteins (Levy et al., 2003). Luciferase reporter assays have also shown
functional differences between Meq and Meq plus c-Jun in thatFig. 3. Luciferase assays demonstrate that MeqFos has functional transactivation and repres
(C) pp14 promoter or (D) 3X-Ori luciferase reporter plasmids and pcDNA (empty vector), pcD
activate the meq promoter and repress the pp38/14 bidirectional promoters and 3X-Ori. Ho
expressed as fold difference relative to pcDNA vector. Signiﬁcance (⁎) equals p≤0.05. Erroralthough Meq activated the AP-1 containing meq promoter, Meq plus
c-Jun resulted in higher activation. Furthermore, Meq expression was
shown to repress the pp38/pp14 bidirectional promoter that contains
the GaHV-2 Ori (Levy et al., 2003). Therefore, luciferase assays were
performed to test the DNA binding and transactivation/repression
functions of MeqFos.
Luciferase assays were utilized to test the transactivation or
repressive functions of MeqFos compared to parental Meq. DF-1 cells
were transfected with pcDNA empty vector, pcDNA-Meq, pcDNA-
MeqFos, pcDNA-c-Jun, or a combination of pcDNA-Meq, pcDNA-
MeqFos, and pcDNA-c-Jun, together with reporter vectors pGL3-meq,
pGL3-pp14, pGL3-pp38, or pGL2-3X-Ori. As shown in Fig. 3A, Meq
activated the meq promoter, however MeqFos required co-transfec-
tion with pcDNA-c-Jun for transactivation, therefore indicating
heterodimerization of MeqFos with c-Jun is required for transactiva-
tion. Since Meq homodimers were previously shown to bind the
GaHV-2 Ori, which is located in the pp38/14 promoter, it was
speculated that Meq homodimers mediated repression of the pp38/
14 promoter (Levy et al., 2003). However, our results show that both
Meq and MeqFos repressed pp38 and pp14 promoters and the pGL2-
3X-Ori reporter, which contains three copies of the GaHV-2 Ori (Fig.sion activities. (A) DF-1 cells were transfected with meq-promoter, (B) pp38 promoter,
NA-Meq, pcDNA-MeqFos, or pcDNA c-Jun, with or without c-Jun. BothMeq andMeqFos
wever, activation of the meq promoter by MeqFos requires c-Jun. Luciferase values are
bars indicate SD.
Fig. 4. In vitro soft agar assays demonstrating that MeqFos has reduced transformation potential. (A) Top panel: immunoﬂuorescence analysis of Meq expression from pools of
selected DF-1 cells transfected with pcDNA, pcDNA-Meq, pcDNA-MeqFos. Bottom panel: Soft agar assay was performed using pcDNA, pcDNA-Meq, pcDNA-MeqFos selected DF-1
cells to assess anchorage independent growth. (B) Number of colonies N100 μm observed in cells expressing pcDNA, pcDNA-Meq, or pcDNA-MeqFos. Average number of colonies
counted from three random ﬁelds are shown. Error bars indicate SD.
Fig. 5. Southern blot analysis of recombinant viruses genomic DNA. (A) rMd5 and
rMd5-MeqFos DNA was digested with EcoRI and probed with total viral MDV cosmid
DNA. (B), rMd5 and rMd5-MeqFos DNA was digested with Pst and probed with EcoQ
fragment. The restriction proﬁle of rMd5-MeqFos is similar to that of rMd5, indicating
no gross genome rearrangements incurred.
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MeqFos to the meq promoter and 3X-Ori was further conﬁrmed by
chromatin immunoprecipitation (ChIP) assay (data not shown).
Colony formation in soft agar
Colony formation in soft agar is a marker of transformation, and
Meq expression in ﬁbroblasts has been shown to promote anchorage
independent growth (Levy et al., 2005). Soft agar assay was employed
to test the ability ofMeq heterodimers to promote colony formation in
soft agar. Meq and MeqFos expression in selected DF-1 cells was
conﬁrmed by IFA (Fig. 4A top panel). As expected, selected DF-1 cells
expressing the pcDNA-Meq construct formed large colonies in soft
agar when compared to control cells selected with pcDNA empty
vector (Fig. 4A bottom panel). Furthermore, cells expressing pcDNA-
Meq had 25× more colonies, N100 μm in size, compared to pcDNA
control cells. In contrast, DF-1 cells expressing pcDNA-MeqFos only
had 3.5×as many colonies N100 μm in size compared to empty vector
control cells (Fig. 4B), indicating that MeqFos heterodimers have a
reduced potential to confer anchorage independent growth.
Construction of a Meq-heterodimer mutant virus rMd5-MeqFos
A recombinant Md5 mutant virus in which the leucine zipper
region of meq was replaced with the corresponding region of Fos
(rMd5-MeqFos) was successfully constructed. The leucine zipper
region of themeq gene was replaced with the leucine zipper region of
Fos by overlapping PCR, and the EcoQ fragment containing the
chimeric meqFos gene was cloned into the A6Δmeq and SN5Δmeq
cosmids. The resultant cosmids A6-MeqFos and SN5-MeqFos together
with cosmids P89, B40 and SN16 were cotransfected into DEF by the
calcium phosphate method and a recombinant virus was subsequent-
ly recovered by homologous recombination. Southern blot analyses
were performed to assess the integrity of the rMd5-MeqFos viral
genome. Genomic DNA from rMd5 and rMd5-MeqFos infected DEF
was digested with EcoRI and probed with 32P labeled Md5 comids
DNA (Fig. 5A) or digested with PstI and probed with 32P labeled EcoQ
fragment DNA (Fig. 5B). No differences were observed between rMd5
and rMd5-MeqFos digestion patterns conﬁrming the gross integrity of
the recombinant genomes (Fig. 5). A PstI site is located in the leuzine
zipper region of both rMd5 and rMd5-MeqFos, therefore two bands
(3950, 2529 base pairs) are observed in DNA digested with PstI and
probed with EcoQ fragment DNA. Furthermore, the expression of Meq
by rMd5 and rMd5-MeqFos viruses in infected DEF was conﬁrmed by
IFA (Fig. 6A).In vitro and in vivo replication of rMd5-MeqFos
The in vitro growth properties of rMd5-MeqFos were tested, to
assess if the leucine zipper mutations had any effect on virus
replication in vitro. Our results indicate that rMd5 and rMd5-MeqFos
virus replicated similarly at the time points tested (days 0, 2, 4, 6)
(data not shown).
To test the role of Meq heterodimers during in vivo replication,
4-week-old SPF chickens were inoculated with 3000 pfu of rMd5 or
rMd5-MeqFos. Six days after inoculation two randomly selected birds
were euthanized and lymphoid organs (thymus, spleen and bursa of
Fabricius) collected and evaluated for viral lytic antigen (pp38)
expression by IHC. Expression of pp38was present in bursa of Fabricius
(Fig. 7) thymus and spleen (data not shown) of both rMd5 and rMd5-
MeqFos infected chickens, indicating that the leucine zippermutations
in the rMd5-MeqFos virus did not affect early cytolytic infection.
GaHV-2 switches from an active cytolytic infection to a latent
infection approximately 7–8 days PI and virus reactivation can be
observed when latently infected lymphocytes are co-cultured with
ﬁbroblasts (Calnek, 1986). To examine if Meq heterodimers are
involved in the establishment of latency and reactivation, peripheral
Fig. 6. Expression of Meq in DEF cells infected with recombinant viruses. (A) Uninfected DEF, rMd5-Meq, rMd5-MeqFos and rMd5-MeqFos/GCN infected DEF were stained with
rabbit anti-Meq speciﬁc antibodies (100× magniﬁcation). (B) RNA isolated from rMd5, rMd5-MeqFos, and rMd5-MeqFos/GCN infected DEF was examined formeq transcription by
RT-PCR with Meq and leucine zipper speciﬁc primers. The expected 320 bp amplicon was observed in all three viruses examined.
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each group on days 14 and 21 PI (experiment 1) and at day 37 PI
(experiment 3) and co-cultured with DEF. As shown in Table 1, none
or few viral plaques were obtained from PBMC of chickens infected
with rMd5-MeqFos at days 14 days and 21 PI; however, viral antigen
expression in PBMC was conﬁrmed by IFA (data not shown).
Interestingly, reactivation levels comparable to rMd5 were obtained
at day 37 PI from one out of three chickens in rMd5-MeqFos infected
chickens (Table 1). To assess if any mutations in the MeqFos gene
incurred, whichmay have contributed to higher reactivation numbers
observed, theMeqFos genewas sequenced from recovered viruses but
no mutations were detected (data not shown).
Transmission of GaHV-2 occurs after viral replication in feather
follicle epithelium (FFE) and release of infectious dander (Calnek,
2001). Therefore, to assess if the rMd5-MeqFos heterodimer mutant
was able to replicate in the FFE, expression of the lytic viral antigen
pp38 was evaluated in three chickens from each inoculated group by
IHC. Tissues from both rMd5 and rMd5-MeqFos infected groups tested
positive for pp38 antigen indicating the ability of rMd5-MeqFos, like
rMd5, to replicate in the FFE (Fig. 7). To further evaluate virus
transmission, day old SPF chickens were inoculated with 3,000 pfu of
rMd5 or rMd5-MeqFos and housed with three uninfected contact
chicks. Buffy coats were collected from contact chickens 8 weeks PI,
DNA extracted and PCR for Meq performed. Transmission to contact
chickens was conﬁrmed by PCR in two chickens infected with rMd5Fig. 7. Infection of lymphoid tissue and feather follicles of chickens infected with rMd5 and
was carried out using anti-pp38 monoclonal antibody and counterstaining was performedand all three contact chickens infected with rMd5-MeqFos were PCR
positive for meq (data not shown). Altogether these results conﬁrm
that rMd5-MeqFos retains the ability to transmit horizontally by
shedding through the FFE.
Oncogenecity of rMd5-MeqFos
To determine if Meq-Jun heterodimers are sufﬁcient for in vivo
transformation of T-cells, groups of ten SPF chickens were inoculated
at day of age with 2,000 pfu of rMd5 or rMd5-MeqFos and observed
for mortality for a period of 8 weeks. All chickens that died during the
experiment or were euthanized at the termination of the experiment
were evaluated for MD-speciﬁc lesions. MD-associated mortality was
observed in rMd5-infected chickens starting at week 4 PI and none of
the chickens survived to the end of the experiment. Only preneo-
plastic lesions were observed in the rMd5-MeqFos group (Fig. 8) and
paralysis was not observed in any of the rMd5-MeqFos infected
chickens.
Oncogenecity of rMd5-MeqFos/GCN
To complement our current study, investigating the role of Meq-
Jun heterodimers in transformation, we recovered a virus, rMd5-
MeqFos/GCN, which contains one copy of the mutant MeqGCN gene
and one copy of the MeqFos gene. Meq expression by rMd5-MeqFos/rMd5-MeqFos. IHC of bursa of Fabricius and feather follicles, 6 and 21 dpi, respectively,
with hematoxylin. Positive cells are indicated by black staining.
Table 1
Virus reactivation from peripheral blood lymphocytes.a
Days post inoculation
Group 14 21 37b
rMd5 121
181
75
28
120
123
116.5
118.5
129
rMd5-MeqFos 0
1
5
0
0
0
2.5
8
133.5
rMd5-MeqFos/GCN ND ND 1.5
4
158
a Numbers represent the average number of pfu observed when 106 peripheral blood
lymphocytes were co-cultured with DEF form each chicken in duplicate.
b Samples were collected from chickens from experiment 2.
Table 2
Pathogenicity of rMd5, rMd5-MeqFos, rMd5-MeqFosR and rMd5-MeqFos/GCN in SPF
MDV maternal antibody-negative chickens.
Virus MDV
mortality (%)
Histological lesions (%)
Preneoplastic Neoplastic
rMd5 10/10 (100) ND ND
rMd5-MeqFos 0/10 (0) 4/8 (50) 0/0 (0)
rMd5-MeqFosRa 3/3 (100) ND ND
rMd5-MeqFos/GCN 2/10 (20) 6/10 (60) 2/10 (20)
Uninfected 0/8 (0) 0/3 (0) 0/3 (0)
a Performed as an independent experiment.
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lack of Fos and GCN4 leucine zipper speciﬁc antibodies, transcription
of both MeqFos and MeqGCN in DEF infected with rMd5MeqFos/GCN
was conﬁrmed by RT-PCR (Fig. 6B).
To study if both Meq homodimers and Meq-Jun heterodimers
contribute to GaHV-2 transformation, ten SPF chickens were
inoculated at day of age with 2000 pfu of rMd5-MeqFos/GCN.
Preneoplastic lesions were observed in 60% of chickens and paralysis
and neoplastic lesions in 20% of chickens infectedwith rMd5-MeqFos/
GCN (Fig. 8, Table 2). In addition, one out of three contact chickens
from the rMd5-MeqFos/GCN infected group contained preneoplastic
nerve lesions.
Construction and biological properties of revertant virus rMd5-MeqFosR
To verify that the phenotypic changes observed with rMd5-
MeqFos were due to changes introduced in the leucine zipper region,
a revertant virus was constructed. DNA obtained from rMd5-MeqFos
infected CEF was co-transfected with puriﬁed parental GaHV-2 EcoQ
DNA, which contains themeq gene. A revertant virus, rMd5-MeqFosR,
was selected by plaque puriﬁcation, and screened for the presence of
both parental meq and mutant meqFos genes by PCR. PCR revealed
that of the 102 plaques tested, one contained one copy of the parental
meq gene restored in the viral genome. Three chickens were infected
with 3,000 pfu of rMd5-MeqFosR and by week 5 PI all three were
positive for MD gross tumors, conﬁrming that the attenuatedFig. 8. MDV induced preneoplastic and neoplastic nerve lesions in chickens infected
with rMd5, rMd5-MeqFos and rMd5-MeqFos/GCN. Neoplastic nerve lesions were
observed in rMd5 (diffuse inﬁltration, arrows) and rMd5-MeqFos/GCN (arrows)
infected chickens while preneoplastic lesions (arrows) were observed in chickens
infected with rMd5-MeqFos.phenotype of rMd5-MeqFos was due to the mutations introduced in
the leucine zipper of Meq.
Discussion
In this study, the role of Meq-Jun heterodimers in GaHV-2
transformation was investigated to complement our recent investiga-
tions on the role of Meq/Meq homodimers in pathogenesis
(Suchodolski et al., 2009). We previously showed that rMd5-
MeqGCN, a recombinant Meq homodimer, is non-oncogenic, support-
ing the concept that Meq/c-Jun heterodimers play a role in
transformation. The results of the current study further dissect the
functions of Meq homodimers and heterodimers in GaHV-2 patho-
genesis and we demonstrate that together bothMeq homodimers and
heterodimers contribute to transformation of chicken lymphocytes.
In order to assess the functions ofMeq-Junheterodimers in GaHV-2
pathogenesis, a recombinant virus in which the leucine zipper of the
Meq protein was replaced with the leucine zipper of c-Fos was
successfully generated. We took advantage of the fact that the leucine
zipper of c-Fos exclusively heterodimerizes with the Jun family of
transcription factors (Kouzarides and Ziff, 1989; Ransone et al., 1990;
Vogt, 2001) and generated aMeqFos chimeric gene.We also generated
an additional virus containing one copy of the previously described
MeqGCN (homodimer) gene and one copy ofMeqFos (heterodimer) to
evaluate the combined transforming capacity of both Meq mutant
genes.
The role of Meq-Jun heterodimers in rMd5 pathogenesis was
investigated by evaluating both viral replication, latency/reactivation
and transformation properties of rMd5-MeqFos in vivo. In vitro, rMd5-
MeqFos replicated similar to parental virus (data not shown) and in
vivo, early cytolytic infection was similar to parental virus in lymphoid
organs as assessed by expression of lytic protein pp38 (Fig. 7). As the
FFE is the site of fully productive infection and source of horizontal
transmission (Calnek, Adldinger, and Kahn, 1970), we evaluated
replication of rMd5-MeqFos in the FFE by IHC and transmission to
contact chickens. Our results show that Meq heterodimerization did
not interfere with either replication in the FFE or transmission to
contact chickens. These results are not unexpected as Meq is not
required for replication in lymphoid organs or FFE (Lupiani et al., 2004).
We previously reported the rMd5-MeqGCN appeared to be
defective in reactivation and speculated, therefore, that Meq hetero-
dimersmay play a role in reactivation from latency (Suchodolski et al.,
2009). The switch from lytic to latent infection in GaHV-2 occurs
around 7 days PI, and virus from latently infected cells can be
reactivated when co-cultured with ﬁbroblasts in vitro (Calnek, 1986).
In reactivation assays, rMd5-MeqFos, appeared to have impaired
reactivation as none or few viral plaques were obtained at days 14 and
21 PI (Table 1) even though viral antigen expression in PBMC was
conﬁrmed by IFA. Intriguingly, our IFA results show viral pp38
expression was only detected in dividing PBMC. This observation is
similar to latent infection with EBV in Burkitt's lymphomawhere viral
antigen expressionwas only detected in dividingmemory B-cells thus
supporting a true latent infection (Hochberg et al., 2004). These
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reactivation. However, since our assessment was not quantitative, we
cannot dismiss the possibility of decreased viral loads as was observed
in leucine zipper mutants (Brown et al., 2009). Interestingly, at day 37
PI one chicken from rMd5-MeqFos and rMd5-MeqFos/GCN had
viremia comparable to parental rMd5 but a correlation between
high reactivation levels and neoplastic lesions was not evident
(Table 1). Therefore, we can only speculate that host factors may
have contributed to higher reactivation levels in these two chickens.
In order to assess the role of Meq-Jun partnership in GaHV-2
transformation in vivo, SPF chickens were infected with rMd5-MeqFos
and evaluated for MD speciﬁc lesions for an eight-week period. In
agreement with a previous report (Brown et al., 2009), neoplastic
lesions did not develop in chickens infected with rMd5-MeqFos
suggesting that heterodimerization of Meq alone is not sufﬁcient for
transformation of lymphocytes in GaHV-2 infected chicken. In
addition, the revertant virus, rMd5-MeqFosR, generated in our study
showed no difference in pathogenesis, in terms of tumor incidence or
survival time, with parental rMd5 suggesting that the observed
phenotype was due to mutations introduced to confer heterodimer-
ization and not due to additional mutations at secondary sites. In
contrast, the revertant viruses generated by Brown et al. did not fully
restore the pathogenic phenotype (e.g. only 40–60% mortality
compared to 100% for parental virus up to 70 dpi) suggesting that
secondary mutations might have affected the phenotype observed
(Brown et al., 2009).
To study if both Meq homo and heterodimers are involved in
complementing pathways in GaHV-2 pathogenesis, an additional
virus, rMd5-MeqFos/GCN, which contains one copy of MeqFos and
one copy of MeqGCN was generated. Neoplastic lesions and paralysis
were observed in 20% of chickens infected with rMd5-MeqFos/GCN.
These data strongly support that both Meq homo- and heterodimers
are involved in complementing pathways leading to T-cell transfor-
mation. However, rMd5-MeqFos/GCN clearly displayed a phenotype
distinct from rMd5, as visceral tumors were not observed and MD
mortality was signiﬁcantly reduced. It is possible that interactions of
Meq with bZIP proteins other than c-Jun could contribute to GaHV-2
pathogenesis. For example, Meq has been shown to dimerize with
ATF/CREB family members (Levy et al., 2003), which have been
implicated in oncogenesis in other systems (Siu and Jin, 2007;
Vlahopoulos et al., 2008). In addition, the interaction of Meq with
other unknown cellular factors may have been abrogated by
replacement of the parental leucine zipper with Fos and GCN leucine
zippers contributing to decreased transformation. Another possible
explanation for the loss of oncogenicity could be that the mutations
introduced into the Meq lecine zipper could have affected the
generation of meq splice variants and meq antisense open reading
frames observed in wild type viruses (Anobile et al., 2006; Liu,
Soderblom, and Goshe, 2006; Peng et al., 1992; Peng and Shirazi,
1996a, 1996b; Peng et al., 1995). However, the role of these meq
spliced variants and antisense open reading frames as well as Meq
interactions with host factors remains to be determined.
Our in vitro characterization of MeqFos also revealed that under
physiologic conditions MeqFos is recruited to the GaHV-2 Ori and
represses the bidirectional pp38/pp14 promoter (Fig. 3B, C, D).
Therefore, loss of oncogenecity by MeqFos is not a result of lack of
ability to repress pp38/pp14 promoter. These results are in disagree-
ment with those previously reported by EMSA (Brown et al., 2009;
Levy et al., 2003). It is therefore possible that the presence of unknown
cellular factors in the luciferase and Chip assay could contribute to
recruitment of MeqFos to these promoters under physiologic condi-
tions, compared to EMSA analysis that utilized bacterially expressed
truncated Meq proteins.
In summary, this work provides the ﬁrst in vivo evidence that both
Meq homodimers and Meq-Jun heterodimers are involved in
complementing pathways required for GaHV-2 transformation.Since, rMd5-MeqFos/GCN was attenuated compared to parental
rMd5, Meq heterodimerization with other AP-1 members outside
the Jun family such as ATF/CREB may also contribute to GaHV-2
transformation. Further work investigating the role of Meq and ATF/
CREB members will help in developing a better understanding of the
transforming pathways in GaHV-2 pathogenesis.
Materials and methods
Cells and viruses
Primary duck embryonic ﬁbroblasts (DEF) were used for virus
propagation, virus reactivation assay, growth curves and DNA
transfections. Cosmids derived from a very virulent GaHV-2 strain,
Md5 were used to generate recombinant viruses (Reddy et al., 2002).
Revertant virus (rMd5-MeqFosR) was recovered in chicken embry-
onic ﬁbroblasts (CEF). The DF-1 cell line was used for luciferase and
chromatin immunoprecipitation (ChIP) assays (Kim et al., 2001).
Co-immunoprecipitation (co-IP) experiments were performed using
293 T cells. Both DEF and CEF were maintained in Leibowitz–McCoy
(LM 1:1) media supplemented with 5% bovine calf serum (BCS) and
penicillin-streptomycin at 37 °C. DF-1 cells were maintained in LM
media supplemented with 4% fetal bovine serum (FBS) and penicillin-
streptomycin at 37 °C. 293 T cells were maintained in DMEM media
supplemented with 10% FBS and penicillin-streptomycin at 37 °C.
Generation of mutant MeqFos chimeric gene
Mutations in themeq gene were generated as described previously
(Suchodolski et al., 2009) with the exception that the primers used for
overlapping PCR were speciﬁc for the c-Fos leucine zipper. Brieﬂy,
meq-KpnI, which is located within the EcoQ fragment of the Md5
genome and contains the coding sequence formeq nucleotides 1–385,
was mutated by a series of subcloning steps and overlapping PCR.
Overlapping PCR was performed in a combination of three PCR
reactions to replace the leucine zipper region of meq with the leucine
zipper region of c-Fos. Two primary PCR reactions were performed to
generate the 5′ and 3′ ends of meqFos-KpnI fragment. The 5′ reaction
was performed using primers M13R (5′-CAG GAA ACA GCT ATG
AC-3′) and SR1194-Fos Leucine Zipper Reverse (5′-CTC CGC CTG CAG
AGC GGA CTT CTC CTC CTC CAG CTG GTC CGT CTC CGC CTG CAG TTT
GTC TAC ATA GTC CGT CTG CTT CCT-3′). The 3′ end PCR reaction was
performed using primers SR1190 (5′-GAC CGA GAT AGG GTT GAG
TG-3′) and SR1195-Fos Leucine Zipper Forward (5′-GAG AAG TCC GCT
CTG CAG GCG GAG ATA GCC AAC CTG CTG AAG GAG AAG GAG AAG
CTG CGT GTA CAG TTG GCT TGT CAT GAG CCA-3′). Both amplicons
were gel puriﬁed, mixed together and used as templates in a third PCR
reaction with primers M13R and SR1190, generating a full meq-KpnI
fragment containing the Fos leucine zipper in place of themeq leucine
zipper (meq-Fos-KpnI). The meqFos-KpnI fragment was cloned into
the EcoQ fragment, generating EcoQ-MeqFos.
Co-Immunoprecipitation
Co-immunoprecipitation analyses were performed to evaluate
MeqFos heterodimerization. For in vitro heterodimerization assays,
parental meq, MeqFos, and chicken c-Jun were cloned into the
pcDNA3.1 (Invitrogen, Carlsbad, CA) eukaryotic expression vector.
Meq, MeqFos, and c-Jun genes were cloned in frame with HA and Flag
tags to aid in protein detection. The resulting plasmids were denoted
as pHA-MeqFos, pFlag-MeqFos, pHA-Meq, pFlag-Meq, and pJun-HA.
293 T cells were cotransfected with 2 μg of either pFlag-Meq or
pFlag-MeqFos and 2 μg of pHA-Meq, pHA-MeqFos, or pJun-HA using
Fugene 6 (Roche, Mannheim, Germany). Cells were harvested 48 h
after transfection and lysed in TNE buffer (10 mM Tris (pH 7.5),
150 mM NaCl, and 0.2 mM EGTA) containing 1 mM DTT. Cell lysates
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conjugated agarose beads (Sigma, St. Louis, MO). Immune complexes
were captured with 20 μl of a protein A and protein G sepharose bead
mixture and rocked for an additional 2 h at 4 °C. Beads were washed
four times with TNE buffer and boiled for 5 min in 20 μl of 2×sodium
dodecyl sulfate (SDS) sample buffer (125 mM Tris–HCl [pH 6.8], 4%
SDS, 10% 2-mercaptoethanol, 20% glycerol, 0.6% bromphenol blue)
subjected to SDS-PAGE electrophoresis and transferred to PVDF
membranes. After blocking for 1 h at room temperature (RT) with 5
% skim milk in TBST (20 mM Tris–HCl [pH 7.5], 137 mM NaCl, 0.05%
Tween 20), the membranes were incubated with a 1:500 dilution of
anti-HA tag antibody (Convance, Berkley, CA) for 2 h at RT. The
membraneswerewashedwith TBST three times for 10min each at RT,
and incubated with horseradish peroxidase-conjugated antibodies
for 1 h at RT. Membranes were washed three times with TBST and
visualized with Super Signal West Pico Chemiluminescent Substrate
(Thermo Scientiﬁc, Rockford, IL).
Luciferase assays
The transactivation/repression activity of the MeqFos protein on
GaHV-2 promoters was evaluated by luciferase assay. The previously
described meq, pp38, pp14 and GaHV-2 Ori promoter constructs
(Suchodolski et al., 2009) were used for luciferase assays. Meq,
MeqFos, and c-Jun genes were cloned into the pcDNA 3.1 Zeo vector
(Invitrogen) to generate expression vectors, pcDNA-Meq, pcDNA-
MeqFos, and pcDNA-Jun. DF-1 cells (1×105) were seeded in 12-well
plates 16 h prior to transfection and incubated at 37 °C under standard
conditions. Transfectionswere performedusing siPORTXP-1 (Ambion,
Austin, TX), 500 ng of pcDNA (empty vector control), pcDNA-Meq,
pcDNA-MeqFos, or 250 ng of pcDNA-Jun with either 250 ng of
pcDNA-Meq or pcDNA-MeqFos, and either 250 ng of pGL3-meq,
pGL2-Ori, or pGL3-pp14 or pGL3-pp38 promoters. Cell lysates were
harvested 48 h post transfection with active lysis buffer (Promega,
Madison, WI) and luciferase assay performed using a Biotek Clarity
luminometer (Biotek, Winooski, VT). The protein concentration in
each transfected sample was measured by Bradford assay (Bio-Rad,
Hercules, CA) and luciferase activity was normalized to protein
concentration. Assays were performed in triplicate and three
independent experiments were performed for each reporter vector
tested. Transactivation or transrepression activity was expressed as
the fold differences relative to empty pcDNA vector control. Results of
all three experiments were analyzed by one-way ANOVA followed by
Tukey HSD test using the SPSS®, Version 14.0 software (SPSS Inc.,
Chicago, IL, USA). For all analysis, p≤0.05 was considered statistically
signiﬁcant.
Colony formation in soft agar
DF-1 cells were transfected with pcDNA, pcDNA-Meq or pcDNA-
MeqFos using siPORT XP-1 (Ambion). Approximately 48 h after
transfection, the transfected DF-1 cells were selected with 300 μg/ml
zeocin (Invitrogen) for 4 weeks. Expression of Meq was conﬁrmed by
IFA using rabbit anti-Meq antibodies as described below. Pools of
resistant cells (5×103) were seeded in 0.33% agarose containing LM
media with 150 μg/ml zeocin and 10% FBS overlaid on a 0.5% agarose
in a 35 mm plate. After 3 weeks of culture, colonies were examined
under a light microscope and photographed using 12× magniﬁcation.
Three different ﬁelds were randomly selected and colonies greater
than 100 μm were counted. Two independent experiments were
performed and each experiment was performed in triplicate.
Cosmids
Previously described cosmids, SN5, P89, SN16, A6 and B40,
encompassing the entire genome of the very virulent strain Md5(Reddy et al., 2002) were used to generate a recombinantMd5 (rMd5)
virus and a recombinantMd5with a chimericMeq gene containing the
leucine zipper from c-Fos (rMd5-MeqFos) (Fig. 1). The EcoQ-MeqFos
generated as indicated above was subsequently cloned into cosmids
A6ΔEcoQ and SN5ΔEcoQ using recA assisted restriction endonuclease
digestion (RARE) yielding cosmids SN5-MeqFos and A6-MeqFos.
Transfections
Viral inserts were released from parental and mutant cosmid DNA
by digestion with NotI and puriﬁed by phenol chloroform extraction
and ethanol precipitation before transfection. The calcium phosphate
procedure was used to transfect 1.2 x106 DEF in 60 mm dishes with
500 ng of cosmids P89, SN16, and B40 in combination with SN5 and
A6, or SN5-MeqFos and A6-MeqFos, or SN5-MeqFos and A6-MeqGCN,
to generate rMd5, rMd5-MeqFos, and rMd5-MeqFos/GCN, respec-
tively. Five days after transfection, cells were trypsinized and seeded
onto fresh DEF monolayers and monitored for cytopathic effect. Viral
stocks of recovered viruses were subsequently made and titrated in
DEF for further analysis.
Southern blot
DNA from rMd5 and rMd5-MeqFos infected DEF was isolated by
proteinase K digestion followed by phenol-chloroform extraction and
ethanol precipitation. Three micrograms of each DNA sample was
digested with EcoRI or PstI, separated on a 1% agarose gel, and
transferred to nylon membranes. 32P-dCTP-labeled probes represent-
ing the complete GaHV-2 genome (cosmids SN5, P89, SN16, A6 and
B40) or EcoQ fragment (2,456 bp)were generated by randompriming,
using High Prime DNA Labeling Kit (Roche), and were hybridized to
digested viral DNA, using standard protocols (Sambrook, 2001).
RT-PCR
RT-PCR was performed to conﬁrm expression of meqFos and
meqGCN genes in DEF infected with rMd5-MeqFos/GCN. Total RNA
was extracted using RNAqueous®-4PCR (Ambion). The reverse
transcriptase reaction was performed using equal amounts of RNA
followed by PCR. Four μl of cDNA were used for subsequent PCR
reactions using primers SR1118-meq start primer (5′-GAT CCC GGG
GAG ATG TCT CAG GAG CCA GAG C-3′) and leucine zipper speciﬁc
primers SR3075-Fos leucine zipper (5′-TTC AGC AGG TTG GCT
ATC-3′), or SR3074-GCN4 leucine zipper (5′-CTA ATT TCT TTA ATC
TGG CAA C-3′).
Generation of revertant virus
CEF were inoculated with rMd5-MeqFos to obtain viral DNA used
for transfections. Gel puriﬁed parental Md5 EcoQ fragment together
with proteinase K digested and phenol-chloroform extracted rMd5-
MeqFos genomic DNA, were used to co-transfect CEF by the calcium
phosphate procedure. After viral plaques were evident, individual
viral plaques were isolated as described (Suchodolski et al., 2009).The
presence of parental meq or Fos leucine zipper sequences from
individual plaques were detected by PCR using the following primers:
SR1118-meq start primer and leucine zipper speciﬁc reverse primers
SR3073-meq leucine zipper (5′-GTC CTT AGA TCT CGA ATT TCC-3′)
or SR3075-Fos leucine zipper, for parental and Fos leucine zippers,
respectively.
Indirect immunoﬂuorescence assay (IFA) and immunohistochemistry (IHC)
Conﬂuent DEF monolayers were infected with rMd5 or rMd5-
MeqFos, and when viral plaques were apparent, cells were ﬁxed with
ice-cold acetone/alcohol (6:4) and Meq expression evaluated by IFA
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lymphoid organs (thymus, spleen and bursa of Fabricius), and feather
follicles from infected and uninfected chickens were embedded in
optimal cutting temperature compound (Tissue-Tek, OCT, Sakura
Finetek, Torrance, CA), immediately frozen in liquid nitrogen and
stored at−80 °C until use. Six- to 8-μm-thick cryostat sections of tissue
were prepared and ﬁxed with cold acetone at −20 °C for 5 min, and
air-dried. Immunostaining was carried out using H19 pp38 monoclo-
nal antibody (1:3000) and the Vectastain ABC kit (Vector Laboratories,
Burlingame, CA) according to the manufacturer's instructions.
Pathogenesis experiments
Experiment 1
To study the effect of Meq heterodimers on viral replication,
4-week-old SPF chickens (Hy-Vac, Adel, Iowa) were randomly sorted
into experimental groups of nine chickens each. One group remained
as a non-inoculated control, whereas the other groupswere inoculated
subcutaneously with 3,000 PFU of rMd5 or rMd5-MeqFos. At 14 and
21 days post infection (dpi), blood samples, from three randomly
selected chickens, were collected in heparin for reactivation assays
(see below), and were subsequently euthanized for tissue sample
collection. At 6 and 21 dpi lymphoid organs and feather follicles were
collected from two and three chickens, respectively, for IHC.
Experiment 2
To study the role of the Meq heterodimers on oncogenesis, SPF day
old chicks (ten per group) were inoculated subcutaneously with 2,000
PFU of rMd5, rMd5-MeqFos, or rMd5-Meq/Fos/GCN and reared in
modiﬁed Horsfall–Brauer isolation units for 8 weeks. Weekly
mortality was recorded and all chickens were necropsied at time of
death or at termination of the experiments (8 weeks) and evaluated
for MD speciﬁc lesions in the viscera and the nerves. Blood was also
collected from three randomly selected chickens from each group for
reactivation assays at day 37 dpi.
Experiment 3
To study the role of Meq heterodimers on horizontal transmission,
six SPF (Charles River,Wilmington,MA)dayold chickswere inoculated
subcutaneously with 3,000 PFU of rMd5 or rMd5-MeqFos while three
additional uninoculated chicks were reared with each group and
served as contacts to assess horizontal transmission. At 8 weeks post
inoculation buffy coats were obtained from heparinized blood by
centrifugation at 500×g. DNA was extracted using Purelink Genomic
DNA extraction kit (Invitrogen) and PCRwas performed using GaHV-2
speciﬁcMeq primers SR1118 (5′-GAT CCCGGGGAGATGTCT CAGGAG
CCA GAG C-3′) and SR1135 (5′-GAT CCC GGG TCA GGG TCT CCC GTC
ACC TGG AAA CC-3′) to detect the presence of viral genome.
Reactivation assay
Buffy coatswere collected asdescribed above at 14, 21, and37dpi. DEF
monolayers seeded in 35 mm plates were inoculated with 106 lymp-
hocytes in duplicate and viral plaques counted 7 days post inoculation.
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